Histological and immunohistochemical evaluation for the role of bone marrow-derived mesenchymal stem cells to counteract the streptozotocin-induced diabetic changes in the rat parotid gland. | ||
| Al-Azhar Journal of Dental Science | ||
| Volume 27, Issue 3, July 2024, Pages 379-388 PDF (2.27 M) | ||
| Document Type: Review Article | ||
| DOI: 10.21608/ajdsm.2022.154425.1356 | ||
| Authors | ||
| Ashraf Mohamed Emran* 1; Said Mahmoud Hani2; syed bakry ahmed3 | ||
| 1oral biology department - Al-Azhar university | ||
| 2Oral and Dental Biology Department, Faculty of Dental Medicine, Al-Azhar University, Cairo, Egypt | ||
| 3Professor, Department of Zoology, Dean of Faculty of Science, Al-Azhar University. | ||
| Abstract | ||
| Objective: the current study was designed to assess the therapeutic effect of bone marrow-derived mesenchymal stem cells (BMSCs) on parotid glands after streptozotocin induced diabetes in rats. Materials and Methods: 36 Sprague-Dawley rats were divided into 3 groups, 12 rats each. Group I: the animals received 0.1 M sodium citrate buffer intraperitoneally, the vehicle of streptozotocin. GroupII: diabetes mellitus was induced by single intraperitoneal injection of 60 mg/kg of streptozotocin (STZ) dissolved in 0.1 M sodium citrate buffer. Group III: one day after diabetes induction, simgle dose of 2×106 BMSCs suspended in 0.5 ml of phosphate buffer solution (PBS) was injected via intraglandular route. Animals were sacrificed at 7 or 14 days after BMSCs injection, then histological and immunohistochemical studies were done. Result: the experimental stem cell treated group showed better histological features and increased PCNA proliferation more than the untreated group. Conclusion: bone marrow derived stem cell is considered as relatively successful method for the treatment of diabetic induced salivary gland dysfunction. | ||
| Keywords | ||
| parotid gland; stem cells; diabetes | ||
|
Statistics Article View: 194 PDF Download: 167 |
||
